Agios Pharmaceuticals (NasdaqGS:AGIO) Q4 2025 Earnings call February 12, 2026 08:00 AM ET Company ParticipantsBrian Goff - CEOCecilia Jones - CFOMark Breidenbach - Managing DirectorMorgan Sanford - Head of Investor RelationsSarah Gheuens - Chief Medical Officer and Head of Research and DevelopmentTsveta Milanova - Chief Commercial OfficerConference Call ParticipantsAlec Stranahan - Biotechnolology Equity Research AnalystEmily Bodnar - Biotechnolology Equity Research AnalystEric Schmidt - Biotechnology Analy ...

Agios Pharmaceuticals (NasdaqGS:AGIO) Q4 2025 Earnings call February 12, 2026 08:00 AM ET Company ParticipantsBrian Goff - CEOCecilia Jones - CFOMark Breidenbach - Managing DirectorMorgan Sanford - Head of Investor RelationsSarah Gheuens - Chief Medical Officer and Head of Research and DevelopmentTsveta Milanova - Chief Commercial OfficerConference Call ParticipantsAlec Stranahan - Biotechnolology Equity Research AnalystEmily Bodnar - Biotechnolology Equity Research AnalystEric Schmidt - Biotechnology Analy ...

Agios Pharmaceuticals (NasdaqGS:AGIO) Q4 2025 Earnings call February 12, 2026 08:00 AM ET Speaker7Good morning, and welcome to Agios Pharmaceuticals' fourth quarter and full year 2025 conference call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session at the end. Please be advised that this call is being recorded at Agios request. I would now like to turn the call over to Morgan Sanford, Head of Investor Relations at Agios. Please go ahead.Thank you, operat ...